Epicentre Biotechnologies - Ownership and Business Overview

Life ScienceCompany

Epicentre Biotechnologies Ownership

Who owns Epicentre Biotechnologies?

Epicentre Biotechnologies is owned by Illumina. It was acquired on January 11, 2011.

Epicentre Biotechnologies Business Overview

Where is Epicentre Biotechnologies headquartered?

Epicentre Biotechnologies is headquartered in Madison, Wisconsin.

What sector is Epicentre Biotechnologies in?

Epicentre Biotechnologies is a life science company.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view all 172 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 149 by strategics.

Epicentre Biotechnologies, Inc.

5062 Research Park Boulevard, Suite 200,
Madison, Wisconsin 53719
United States,
(608) 442-6100

Epicentre Biotechnologies, Inc. is a provider of nucleic acid sample preparation reagents and specialty enzymes used in sequencing and microarray applications.


 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.